Osteoporosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Osteoporosis Clinical Trials Market Report Overview
In total there were 2,044 clinical trials conducted on osteoporosis, as of April 2022. The Osteoporosis clinical trial market research report provides an overview of the Osteoporosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Osteoporosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Osteoporosis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Osteoporosis clinical trials market are Asia Pacific, Europe, North America, Middle East and Africa, and Central and South America. Asia Pacific accounted for the highest number of Osteoporosis clinical trials as of April 2022.
In a country-wise analysis, the US has the highest number of osteoporosis clinical trials, as of April 2022, followed by Japan, China, Canada, and the UK.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan has the highest proportion of Osteoporosis to Musculoskeletal Disorders clinical trials as of April 2022. Moreover, the majority of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of Osteoporosis to Musculoskeletal Disorders clinical trials as of April 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Osteoporosis Clinical Trials Analysis by Regions
For more regional insights into the Osteoporosis clinical trials market, download a free report sample
Osteoporosis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Osteoporosis clinical trials market are institution, company, and the government. Out of them, the institution segment accounted for the most number of clinical trials as of April 2022.
Osteoporosis Clinical Trials Market Analysis by Sponsor Types
For more sponsor-type insights into the Osteoporosis clinical trials market, download a free report sample
Osteoporosis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Osteoporosis clinical trials market are Novartis AG, Eli Lily and Co, F. Hoffmann-La Roche Ltd, Amgen Inc, Merck & Co Inc, Takeda Pharmaceutical Co Ltd, Sanofi, GSK, Pfizer Inc, and Radius Health Inc. Novartis AG held the largest number of Osteoporosis clinical trials as of April 2022.
Osteoporosis Clinical Trials Market Analysis by Sponsors
To know more about the leading Osteoporosis clinical trials market players, download a free report sample
Osteoporosis Clinical Trials Market Report Overview
Key Regions | Asia Pacific, Europe, North America, Middle East and Africa, and Central and South America |
Key Countries | The US, Japan, China, Canada, United Kingdom, Denmark, Australia, Italy, France, and Spain |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Novartis AG, Eli Lily and Co, F. Hoffmann-La Roche Ltd, Amgen Inc, Merck & Co Inc, Takeda Pharmaceutical Co Ltd, Sanofi, GSK, Pfizer Inc, and Radius Health Inc |
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reason for unaccomplishment
- The report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies about investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Eli Lilly and Co
Amgen Inc
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Takeda Pharmaceutical Co Ltd
Sanofi
GlaxoSmithKline Plc
Pfizer Inc
Radius Health Inc
Table of Contents
Frequently asked questions
-
What are the key regions in the Osteoporosis clinical trials market?
The key regions in the Osteoporosis clinical trials market are Asia Pacific, Europe, North America, Middle East and Africa, and Central and South America.
-
What are the key countries in the Osteoporosis clinical trials market?
The key countries in the Osteoporosis clinical trials market are the US, Japan, China, Canada, United Kingdom, Denmark, Australia, Italy, France, and Spain.
-
What are the key sponsor types in the Osteoporosis clinical trials market?
The key sponsor types in the Osteoporosis clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Osteoporosis clinical trials market?
The leading sponsors in the Osteoporosis clinical trials market are Novartis AG, Eli Lily and Co, F. Hoffmann-La Roche Ltd, Amgen Inc, Merck & Co Inc, Takeda Pharmaceutical Co Ltd, Sanofi, GSK, Pfizer Inc, and Radius Health Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Musculoskeletal Disorders reports

